About TissUse
TissUse is a Healthcare company based in Berlin (Germany) founded in 2010. Multi-organ chip platform for tissue culture is developed. The company has 31 employees. Its chief executive, as recorded, is Reyk Horland. TissUse offers products and services including HUMIMIC Devices, HUMIMIC Chips, HUMIMIC Accessories and Cells, and Custom Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Microfluidics. Its legal entity is TissUse GmbH.
Company details
TissUse was founded in 2010 in Berlin, Germany, within the biotechnology sector. A multi-organ chip platform based on human-on-a-chip technology is developed by the company. HUMIMIC devices, chips, cells, and accessories are provided for in vitro simulations of human organ activities. These tools are utilized for toxicity assessments, ADME profiling, and efficacy testing, thereby reducing reliance on laboratory animal experiments.
- Headquarters Berlin, Germany
- Employees 31
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tissuse.com/en
- Social LinkedIn X
- Legal Name Tissuse Gmbh
- Latest Funding Round$796.02K (USD), Grant
Jun 2021
- InvestorsEuropean Union
& 1 more
- Employee Count31
Products & Services of TissUse
TissUse offers a comprehensive portfolio of products and services, including HUMIMIC Devices, HUMIMIC Chips, HUMIMIC Accessories and Cells, and Custom Services.
Miniaturized constructs simulating human organ activity
Components for multi-organ chip platforms in testing
Accessories and cells for human-on-a-chip systems
Contracts for safety evaluation of drugs and chemicals
Funding Insights of TissUse
- Total Rounds 7
- Last Round Grant — $796,018
- Investors Count 2
All 7 funding rounds of TissUse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $796,018 | Grant | – | – | |
| Mar 2021 | $601,964 | Grant | – | – | |
| Dec 2020 | $96,916 | Grant | – | – | |
| Mar 2019 | $17,214 | Grant | – | – | |
| Jan 2019 | Grant | – | – | ||
| Jan 2016 | $754,841 | Grant | – | – | |
| Jun 2013 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in TissUse
TissUse has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and TU Berlin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
University offering multiple courses and degrees across diversified streams | 1879 | tu.berlin | Berlin, Germany |
Investor details for TissUse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TissUse
1 people are tracked at TissUse (1 in leadership); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Reyk Horland | CEO | Leadership |
Complete people profiles for TissUse
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TissUse
3 dated milestones of TissUse across 11 years, from founding to its latest funding, stage changes and deals.
- Founded TissUse is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $796K.
Web traffic of TissUse
The website of TissUse (tissuse.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 28.2% vs previous month
Websites whose visitors overlap most with TissUse. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
scheringstiftung.de | scheringstiftung.de | 100% | #3,100,887 | – | |
mpi-cbg.de | mpi-cbg.de | 87% | #331,615 | – | |
bihealth.org | bihealth.org | 83% | #616,391 | – | |
tib-molbiol.com | tib-molbiol.com | 79% | – | ||
| mdc-berlin.de | 76% | 144.6K | #230,099 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for TissUse
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tissuse
Complete news archive for TissUse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TissUse
TissUse was founded in 2010 and raised its 1st funding round 3 years after it was founded.
TissUse is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Reyk Horland is the CEO of TissUse, as recorded in our data.
TissUse has 31 employees.
TissUse was founded in 2010 in Berlin, Germany, within the biotechnology sector. A multi-organ chip platform based on human-on-a-chip technology is developed by the company. HUMIMIC devices, chips, cells, and accessories are provided for in vitro simulations of human organ activities. These tools are utilized for toxicity assessments, ADME profiling, and efficacy testing, thereby reducing reliance on laboratory animal experiments.
TissUse offers HUMIMIC Devices, HUMIMIC Chips, HUMIMIC Accessories and Cells, and Custom Services.
TissUse has 2 investors. Key investors include European Union, and TU Berlin.
TissUse operates through Tissuse Gmbh.